PBH
PBH
NYSE · Pharmaceuticals

Prestige Consumer Healthcare

$52.54
-2.05 (-3.76%)
As of May 9, 1:24 AM ET ·
Analyst Consensus
Strong Buy
10
Analysts
Moderate
Coverage
Buy 8 80%
Hold 2 20%
Sell 0 0%
Price Target
Analyst Price Target +48.7% upside
Low Target $50.25
Average Target $78.15
High Target $108.25
Current Price $52.54
Current
$52.54
Target
$78.15
$50.25 $78.15 avg $108.25
Scenario Analysis
Bear Case
$50.25
-4.4%
Low target
Base Case
$78.15
+48.7%
Avg target
Bull Case
$108.25
+106.0%
High target
Risk/Reward
24.3x
Highly favorable
Price in Context
52-Week High
$89.37
-41.2% from high
52-Week Low
$51.24
+2.5% from low
50-Day SMA
$64.04
-18.0% vs SMA
200-Day SMA
$69.15
-24.0% vs SMA
RSI (14)
68.6
Neutral
Target vs 52W High
$78.15
-12.6% vs high
Next Earnings Report
May 13, 2026 · After Market Close
2d
until earnings
EPS Est: $1.40
Earnings in 2 days. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
RDY
Dr. Reddy's Laboratories
Hold 45 51% +0.0%
LLY
Eli Lilly and Co.
Strong Buy 39 77% $1,330.33 +40.3%
JNJ
Johnson & Johnson
Buy 32 63% $299.55 +35.3%
MRK
Merck & Co. Inc.
Buy 35 71% $159.27 +43.0%
PFE
Pfizer Inc.
Hold 36 44% $33.90 +32.0%
BMY
Bristol-Myers Squibb Co
Hold 36 42% $174.50 +210.7%
ZTS
Zoetis Inc
Buy 25 60% $209.87 +153.4%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -28.6%